Contact Us
  Search
The Business Research Company Logo
Digital Pathology Slide Scanner Market Report 2026
Published :July 2026
Pages :250
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

Digital Pathology Slide Scanner Market Report 2026

Global Outlook – By Product Type (Brightfield, Fluorescence, Other Product Types), By Technology (Whole Slide Imaging, Live View Scanning, Z Stack Scanning Or Focus Stacking, Confocal Scanning, Other Technologies), By Slide Capacity (Low Capacity Scanners, Medium Capacity Scanners, High Capacity Scanners), By Application (Disease Diagnosis, Academic Research, Drug Discovery, Other Applications), By End User (Hospitals, Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030

Digital Pathology Slide Scanner Market Overview

• Digital Pathology Slide Scanner market size has reached to $1.04 billion in 2025 • Expected to grow to $1.82 billion in 2030 at a compound annual growth rate (CAGR) of 11.8% • Growth Driver: Rising Prevalence Of Cardiovascular Diseases Driving Market Growth Due To Sedentary Lifestyles And Poor Dietary Habits • Market Trend: Advancing Diagnostic Imaging With High-Speed Whole-Slide Scanning And Multi-Mode Histopathology Analysis • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Digital Pathology Slide Scanner Market?

A digital pathology slide scanner is a medical imaging device that converts physical glass pathology slides into high-resolution digital images. It uses advanced optics and scanning technology to capture detailed tissue structures at various magnifications for analysis. These digital slides can then be stored, shared, and examined on computer systems to support diagnosis, research, and remote pathology workflows. The main product types of digital pathology slide scanner include brightfield, fluorescence, and other product types. Brightfield refers to scanners designed to capture standard stained tissue slides for routine pathological examination and diagnosis. These systems are based on technologies such as whole slide imaging, live view scanning, z stack scanning or focus stacking, confocal scanning, and other technologies and are categorized by slide capacity including low capacity scanners, medium capacity scanners, and high capacity scanners. The various applications involved are disease diagnosis, academic research, drug discovery, and others, and they are used by several end users such as hospitals, diagnostic laboratories, academic and research institutes, pharmaceutical and biotechnology companies, and others.
Digital Pathology Slide Scanner Market Bar Graph

What Is The Digital Pathology Slide Scanner Market Size and Share 2026?

The digital pathology slide scanner market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.16 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to manual microscopy based diagnosis dependency, limited storage and archival capacity for glass slides, low scanner resolution and high equipment cost, slow adoption of digital laboratory systems, shortage of skilled pathology workforce in remote regions.

What Is The Digital Pathology Slide Scanner Market Growth Forecast?

The digital pathology slide scanner market size is expected to see rapid growth in the next few years. It will grow to $1.82 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising adoption of telepathology, increasing demand for precision medicine diagnostics, expansion of hospital laboratory automation, growing need for data driven diagnostic workflows, increasing investment in cancer diagnostics infrastructure. Major trends in the forecast period include increasing adoption of remote pathology collaboration networks, rising demand for standardized digital slide archiving and retention compliance, expansion of high-throughput screening workflows in clinical pathology labs, growing emphasis on regulatory compliance and quality assurance in digital diagnostics, increasing investment in ergonomic and user-friendly slide scanner hardware design.
Research Expert

Book your 30 minutes free consultation with our research experts

Global Digital Pathology Slide Scanner Market Segmentation

1) By Product Type: Brightfield, Fluorescence, Other Product Types 2) By Technology: Whole Slide Imaging, Live View Scanning, Z Stack Scanning Or Focus Stacking, Confocal Scanning, Other Technologies 3) By Slide Capacity: Low Capacity Scanners, Medium Capacity Scanners, High Capacity Scanners 4) By Application: Disease Diagnosis, Academic Research, Drug Discovery, Other Applications 5) By End User: Hospitals, Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Brightfield: Clinical Diagnostic Imaging, Histopathology Imaging, Cytology Imaging, Routine Tissue Examination Imaging, High Throughput Slide Imaging 2) By Fluorescence: Immunofluorescence Imaging, Molecular Marker Imaging, Protein Expression Imaging, Cellular Structure Imaging, Multichannel Fluorescence Imaging 3) By Other Product Types: Hybrid Imaging Systems, Multimodal Imaging Systems, Spectral Imaging Systems, Advanced Contrast Imaging Systems, Specialized Research Imaging Systems

What Is The Driver Of The Digital Pathology Slide Scanner Market?

The rising prevalence of cardiovascular diseases is expected to propel the growth of the digital pathology slide scanner market going forward. Cardiovascular diseases are conditions affecting the heart and blood vessels, including coronary heart disease, stroke, heart failure, and arrhythmias. The prevalence of cardiovascular diseases is growing due to aging populations, as advancing age significantly increases the risk of developing heart and vascular conditions, particularly among those over 65 years. Digital pathology slide scanner enables high-resolution digitization and analysis of tissue samples, helping detect microscopic vascular and cardiac abnormalities more accurately and supporting improved diagnosis and research in cardiovascular diseases. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease caused 919,032 deaths, representing roughly one-third of all deaths. Coronary heart disease continued to be the most common type, with approximately one in six cardiovascular deaths occurring in adults under the age of 65. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the digital pathology slide scanner industry.

Key Players In The Global Digital Pathology Slide Scanner Market

Major companies operating in the digital pathology slide scanner market are F. Hoffmann-La Roche AG, Danaher Corporation, Koninklijke Philips N.V., Evident Corporation, Nikon Corporation, Carl Zeiss AG, Hamamatsu Photonics K.K., Motic China Group Co. Ltd., OptraSCAN Inc., Morphle Labs Inc., Scopio Labs Ltd., 3DHISTECH Ltd., Vieworks Co Ltd, PreciPoint Group GmbH, Hangzhou KFBIO Biotechnology Co. Ltd., Huron Digital Pathology Inc., Mikroscan Technologies Inc., Paige.AI, Proscia Inc., Sectra AB, Indica Labs, Visiopharm.

What Are Latest Mergers And Acquisitions In The Digital Pathology Slide Scanner Market?

In August 2025, Evident Corporation, a Japan-based medical imaging and life sciences company, acquired Pramana Inc. for an undisclosed amount. Through this acquisition, Evident aims to strengthen its digital pathology capabilities by integrating Pramana’s autonomous whole slide imaging (WSI) technologies and AI-powered scanning systems, thereby enhancing its digital pathology slide scanner portfolio and enabling high-throughput slide digitization, workflow automation, and advanced diagnostic imaging. Pramana Inc. is a US-based healthcare technology company that develops fully autonomous digital pathology slide scanners and AI-enabled imaging systems used in hospitals, research laboratories, and academic institutions.

Regional Outlook

North America was the largest region in the digital pathology slide scanner market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Need data on a specific region in this market?

What Defines the Digital Pathology Slide Scanner Market?

The digital pathology slide scanner market consists of revenues earned by entities by providing services such as whole slide imaging services, telepathology consultations, digital slide storage and management, and scanner maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital pathology slide scanner market also includes sales of whole slide imaging systems, automated slide scanners, image analysis software platforms, and digital pathology storage and management systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Digital Pathology Slide Scanner Market Report 2026?

The digital pathology slide scanner market research report is one of a series of new reports from The Business Research Company that provides digital pathology slide scanner market statistics, including digital pathology slide scanner industry global market size, regional shares, competitors with a digital pathology slide scanner market share, detailed digital pathology slide scanner market segments, market trends and opportunities, and any further data you may need to thrive in the digital pathology slide scanner industry. This digital pathology slide scanner market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital Pathology Slide Scanner Market Report Forecast Analysis

Report Attribute Details
Market Size Value In 2026$1.16 billion
Revenue Forecast In 2030$1.82 billion
Growth RateCAGR of 11.8% from 2026 to 2030
Base Year For Estimation2025
Actual Estimates/Historical Data2020-2025
Forecast Period2026 - 2030
Market RepresentationRevenue in USD Billion and CAGR from 2026 to 2030
Segments CoveredProduct Type, Technology, Slide Capacity, Application, End User
Regional ScopeAsia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country ScopeThe countries covered in the digital pathology slide scanner market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Key Companies ProfiledF. Hoffmann-La Roche AG, Danaher Corporation, Koninklijke Philips N.V., Evident Corporation, Nikon Corporation, Carl Zeiss AG, Hamamatsu Photonics K.K., Motic China Group Co. Ltd., OptraSCAN Inc., Morphle Labs Inc., Scopio Labs Ltd., 3DHISTECH Ltd., Vieworks Co Ltd, PreciPoint Group GmbH, Hangzhou KFBIO Biotechnology Co. Ltd., Huron Digital Pathology Inc., Mikroscan Technologies Inc., Paige.AI, Proscia Inc., Sectra AB, Indica Labs, Visiopharm.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options
Chat with us